Search filters

List of works by Min Hee Hong

A phase Ib study of the combination of afatinib and ruxolitinib in EGFR mutant NSCLC with progression on EGFR-TKIs

scientific article published on 28 May 2019

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-cMet Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC

scientific article published on 15 May 2020

Characteristics and outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical Practice.

scientific article

Clinical characteristics of T790M-positive lung adenocarcinoma after resistance to epidermal growth factor receptor-tyrosine kinase inhibitors with an emphasis on brain metastasis and survival.

scientific article

Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma.

scientific article

Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

scientific article published on 25 March 2019

Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization.

scientific article

Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis

scientific article published on 10 May 2017

Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials

scientific article

Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy

scientific article published on 01 August 2019

ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma

scientific article published on 25 September 2017

Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck

scientific article published on 16 October 2017

Enhancer remodeling and microRNA alterations are associated with acquired resistance to ALK inhibitors.

scientific article published on 18 April 2018

Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation

scientific article published on 11 August 2018

Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer

scientific article published on 02 September 2020

High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma

scientific article published on 27 December 2019

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

scientific article published on 01 July 2019

Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives

scientific article published on 27 January 2020

Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer

scientific article published on 30 August 2019

Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma

scientific article published on 03 April 2019

Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing

scientific article published on 25 November 2019

Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate

scientific article published on 26 March 2019

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.

scientific article published on 14 November 2016

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma

scientific article published on 27 December 2019

Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma

scientific article published on 04 August 2020

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane

scientific article published on 09 August 2014

Povidone-iodine for the management of oral mucositis during cancer therapy.

scientific article published on June 2017

Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors

scientific article published on 27 June 2019

Prognosis of pN3 stage gastric cancer.

scientific article published on 30 June 2009

Real-World Analysis of the Efficacy of Rebiopsy and EGFR Mutation Test of Tissue and Plasma Samples in Drug-Resistant Non-Small Cell Lung Cancer

scientific article published on 01 June 2019

Recurrent Sympathetic Ophthalmia with Annular Choroidal Detachment after Pembrolizumab Treatment: A Case Report

scientific article published on 01 July 2019

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer

scientific article published on 08 April 2020

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.

scientific article

Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer

scientific article published on 21 October 2019

Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea

scientific article

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non-Small Cell Lung Cancer

scientific article published on 22 January 2019

Paulina is supported by:

About Paulina

Help